Charles Patti is Chief of Growth at Eleusis, a groundbreaking venture described as the world’s first legal luxury psychedelic research immersion retreat/resort. Eleusis is scheduled to open its first public immersion retreats on March 18th and March 25th on the island of Beckway in Saint Vincent and the Grenadines (SVG).

This location was chosen because the organization secured a rare government license to utilize all psychedelic compounds for research purposes. The Eleusis model is a luxury, medically supervised, research-focused experience that is explicitly distinct from traditional group-based ceremonies like Ayahuasca.

It emphasizes personalized medical care, with all vital signs being monitored and pharmaceutical-grade medicine sourced from a GMP certified laboratory in Canada, representing a "new paradigm" for the therapeutic use of these medicines.